News
Bayer seeks Japanese marketing authorization for low-dose contrast agent, gadoquatrane for contrast-enhanced MRI of all body regions and CNS: Berlin Tuesday, June 3, 2025, 13:00 H ...
Our Bureau, Bengaluru Tuesday, June 3, 2025, 13:30 Hrs [IST] Biocon Pharma Limited has received approval for its lirag ...
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive mHSPC: Basel Tuesday, June 3, 2025, 12:00 Hrs [IST] ...
US FDA accepts for review GSK’s NDA for linerixibat to treat cholestatic pruritus in patients with PBC: London, UK Tuesday, June 3, 2025, 11:00 Hrs [IST] GSK plc announced the U ...
Sanofi to acquire US-based biopharma company, Blueprint Medicines for up to $9.5 billion: Paris Tuesday, June 3, 2025, 09:00 Hrs [IST] Sanofi and Blueprint Medicines Corporation ( ...
Shardul Nautiyal, Mumbai Tuesday, June 3, 2025, 08:00 Hrs [IST] ...
TWN calls for urgent need of stronger scrutiny in granting patents to avoid evergreening: Our Bureau, New Delhi Tuesday, June 3, 2025, 08:00 Hrs [IST] Third World Network (TWN), a ...
IMA terms integrated medical course at JIPMER a ‘regressive step’, urges govt to withdraw proposal: Peethaambaran Kunnathoor, Chennai Tuesday, June 3, 2025, 08:00 Hrs [IST] Cr ...
Pharmexcil urges exporters to participate in EXIM Bank’s Annual Exporter Survey: Shardul Nautiyal, Mumbai Tuesday, June 3, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Promo ...
PCI asks pharmacists to report grievances only through digital portal: Gireesh Babu, New Delhi Tuesday, June 3, 2025, 08:00 Hrs [IST] The Pharmacy Council of India (PCI) has sough ...
CirCode Biomed gets US FDA clearance for IND application of HM2002, the world's first circular RNA drug being administrated in patients: Shanghai, China Monday, June 2, 2025, 18:0 ...
DRI seizes 9.72 kg methamphetamine tablets in Mizoram, one person arrested: Our Bureau, New Delhi Monday, June 2, 2025, 17:15 Hrs [IST] The Directorate of Revenue Intelligence (DR ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results